# Stryker to acquire Inari Medical for $4.9 billion

Stryker announced a definitive agreement to acquire Inari Medical for $80 per share in cash, representing a total equity value of approximately $4.9 billion. Inari provides mechanical thrombectomy solutions for peripheral vascular diseases.

- Type: Acquisition
- Announced: 2025-01-06
- Where: United States
- Value: $4.90B
- Status: announced
- Products: mechanical thrombectomy solutions
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Stryker](https://endata.com/companies/15355.md)
- [Stryker](https://endata.com/companies/15355.md) (acquirer)
- [Viscogliosi Brothers](https://endata.com/companies/38951.md) (acquirer)
- [VB Spine](https://endata.com/companies/38952.md) (target)
- [Inari Medical](https://endata.com/companies/73485.md) (target)

## Sources

- [investors.stryker.com](https://investors.stryker.com/press-releases/news-details/2025/Stryker-announces-definitive-agreement-to-acquire-Inari-Medical-Inc.-providing-entry-into-high-growth-peripheral-vascular-segment/default.aspx), 2025-01-06: "Stryker announced today a definitive agreement to acquire all of the issued and outstanding shares of common stock of Inari Medical, Inc. for $80 per share in cash, representing a total fully diluted equity value of approximately $4.9 billion."
- [stryker.com](https://www.stryker.com/us/en/about/news/2025/stryker-announces-definitive-agreement-to-acquire-inari-medical-inc.html), 2025-01-06: "Inari will bring a leading peripheral vascular position in the fast-growing segment of venous thromboembolism (VTE) to Stryker."
- [evtoday.com](https://evtoday.com/news/stryker-to-acquire-inari-medical), 2025-01-06: "Stryker announced a definitive agreement to acquire Inari Medical, Inc. for approximately $4.9 billion."
- [investors.stryker.com](https://investors.stryker.com/press-releases/news-details/2025/Stryker-announces-definitive-agreement-for-the-sale-of-its-U.S.-spinal-implants-business-and-plans-to-sell-related-international-business/default.aspx), 2025-01-28: "We believe that the spinal implants business, with its comprehensive portfolio and strong sales channel, will thrive as an independent company."
- [orthofeed.com](https://orthofeed.com/2025/02/01/stryker-announces-definitive-agreement-for-the-sale-of-its-u-s-spinal-implants-business-and-plans-to-sell-related-international-business/), 2025-02-01: "We believe that the spinal implants business, with its comprehensive portfolio and strong sales channel, will thrive as an independent company."
- [business.times-online.com](https://business.times-online.com/times-online/article/gnwcq-2025-2-19-stryker-completes-acquisition-of-inari-medical-inc-providing-entry-into-the-high-growth-peripheral-vascular-segment), 2025-02-19: "The acquisition of Inari Medical marks a significant milestone in expanding our interventional endovascular portfolio."
- [medicaldevice-network.com](https://www.medicaldevice-network.com/news/stryker-inari-4-9bn/), 2025-02-20: "The acquisition of Inari Medical marks a significant milestone in expanding our interventional endovascular portfolio."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.